Holen Sie sich die Stockscreener-App
37.95
1.99%
-0.77
Handel nachbörslich:
37.95
Schlusskurs vom Vortag:
$38.72
Offen:
$38.72
24-Stunden-Volumen:
563.21K
Relative Volume:
0.56
Marktkapitalisierung:
$4.27B
Einnahmen:
$14.09M
Nettoeinkommen (Verlust:
$-176.94M
KGV:
-17.65
EPS:
-2.15
Netto-Cashflow:
$-141.24M
1W Leistung:
+6.24%
1M Leistung:
+33.44%
6M Leistung:
+98.38%
1J Leistung:
+122.97%
1-Tages-Spanne:
$37.50
$39.00
1-Wochen-Bereich:
$35.21
$39.03
52-Wochen-Spanne:
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Firmenname
Newamsterdam Pharma Company Nv
Sektor
Branche
Telefon
35 206 2971
Adresse
GOOIMEER 2-35, NARRDEN
Vergleichen Sie NAMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
37.95 | 4.36B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-17 | Eingeleitet | Goldman | Neutral |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-06-10 | Eingeleitet | Stifel | Buy |
| 2025-06-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-15 | Eingeleitet | TD Cowen | Buy |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-18 | Eingeleitet | Guggenheim | Buy |
| 2024-01-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-30 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Share Buyback & Technical Entry and Exit Tips - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantMarket Rally & Community Verified Watchlist Alerts - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potential2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzed2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.M&A Rumor & AI Driven Price Forecasts - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earnings - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Top Decliners & AI Driven Stock Reports - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervalued2025 Dividend Review & Community Shared Stock Ideas - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideQuarterly Market Summary & Safe Capital Growth Trade Ideas - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stock2025 Year in Review & Free Community Consensus Stock Picks - newser.com
NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance - Markets Mojo
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outBuy Signal & Fast Moving Stock Watchlists - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Published on: 2025-11-02 01:19:15 - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
How to build a custom watchlist for NewAmsterdam Pharma Company N.V.Earnings Miss & Daily Entry Point Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthWeekly Investment Summary & Accurate Trade Setup Notifications - newser.com
NewAmsterdam Pharma (NAMS) Is Up 6.2% After Announcing Key Phase 3 Data Reveal at AHA 2025—Has The Bull Case Changed? - simplywall.st
Will NewAmsterdam Pharma Company N.V. stock maintain dividend yieldPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Can NewAmsterdam Pharma Company N.V. stock resist sector downturnsJuly 2025 Review & Consistent Income Trade Ideas - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonForecast Cut & Daily Profit Focused Screening - newser.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsTrend Reversal & Consistent Growth Stock Picks - newser.com
How NewAmsterdam Pharma Company N.V. stock trades during market volatilityGlobal Markets & Stepwise Trade Execution Plans - newser.com
Volatility clustering patterns for NewAmsterdam Pharma Company N.V.Quarterly Portfolio Report & Entry and Exit Point Strategies - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalMarket Trend Report & Consistent Income Trade Ideas - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from commodity pricesJuly 2025 Selloffs & AI Driven Price Predictions - newser.com
Jennison Associates LLC Sells 1,024,086 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):